Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, presenting promising developments throughout several health care and industrial apps. With its structural similarity to In a natural way derived human serum albumin, OsrHSA offers a safer, much more responsible alternative for therape